156 related articles for article (PubMed ID: 1520771)
21. Monoclonal antibodies to endotoxin in the management of sepsis.
Fang KC
West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies in sepsis.
Sheppard MJ; Kelly TW
BMJ; 1992 Apr; 304(6833):1054-5. PubMed ID: 1586799
[No Abstract] [Full Text] [Related]
23. Human monoclonal antibodies in sepsis.
de Koning J; Westendorp RG
Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215
[No Abstract] [Full Text] [Related]
24. Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.
Hurley JC
Drugs; 1994 Jun; 47(6):855-61. PubMed ID: 7521827
[No Abstract] [Full Text] [Related]
25. [Monoclonal antibodies in the treatment of septic shock].
Trilla A; Alonso P
Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
[No Abstract] [Full Text] [Related]
26. [A cost-efficacy analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis].
Badía X; Segú L; García Alonso F; Rovira J
Med Clin (Barc); 1993 Jan; 100(3):84-9. PubMed ID: 8426499
[TBL] [Abstract][Full Text] [Related]
27. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR
Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341
[TBL] [Abstract][Full Text] [Related]
28. Survival in selected patients with gram-negative sepsis after adjunctive therapy with HA-1A.
van Dissel JT; van Furth R; Compier BA; Feuth HD; Frolich M
Lancet; 1993 Apr; 341(8850):959-60. PubMed ID: 8096292
[No Abstract] [Full Text] [Related]
29. Therapies directed against endotoxin--has the time come?
Quezado ZM; Hoffman WD
West J Med; 1993 Apr; 158(4):424-5. PubMed ID: 8317138
[No Abstract] [Full Text] [Related]
30. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
Abraham E
West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
[No Abstract] [Full Text] [Related]
31. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
[TBL] [Abstract][Full Text] [Related]
32. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis.
Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ
Crit Care Med; 1992 Jun; 20(6):730-5. PubMed ID: 1597023
[TBL] [Abstract][Full Text] [Related]
33. [Septomonab (Centoxin) in the treatment of gram-negative septicemia].
Fomsgaard A
Ugeskr Laeger; 1993 Apr; 155(14):1066-71. PubMed ID: 8497944
[No Abstract] [Full Text] [Related]
34. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
Talan DA
Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
[TBL] [Abstract][Full Text] [Related]
35. Role of immunomodulator therapy in sepsis.
Caplan ES
Am J Surg; 1993 Feb; 165(2A Suppl):20S-25S. PubMed ID: 8438996
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.
Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW
J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255
[TBL] [Abstract][Full Text] [Related]
37. Update on antiendotoxin therapies.
Stephens R; Hamilton-Davies C
Hosp Med; 2000 Apr; 61(4):254-8. PubMed ID: 10858802
[TBL] [Abstract][Full Text] [Related]
38. Vaccines and antibodies in the prevention and treatment of sepsis.
Bhattacharjee AK; Cross AS
Infect Dis Clin North Am; 1999 Jun; 13(2):355-69, vii. PubMed ID: 10340171
[TBL] [Abstract][Full Text] [Related]
39. Update on monoclonal antibody therapy in the gram-negative sepsis syndrome.
Hecker RB
J Am Osteopath Assoc; 1992 Aug; 92(8):1017-20. PubMed ID: 1429060
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antiendotoxin agent HA-1A (Centoxin).
Inglis TJ; Hawkey PM; Lacey RW; Bodeham A; Kay E; Calvert RT
Lancet; 1993 Jan; 341(8840):303. PubMed ID: 8093933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
